Teva Secures Solar Power with Enery's Bulgarian Project

Sep 24, 2025 10:08 AM ET
  • Teva partners with Enery for a 15-year solar power deal, advancing sustainable energy in pharmaceuticals with a 122-MW solar farm in Bulgaria.
Teva Secures Solar Power with Enery's Bulgarian Project

Teva Pharmaceutical Industries has entered into a 15-year power purchase agreement with Austrian renewable energy company Enery. This deal involves Teva purchasing electricity from a new 122-MW solar farm, which includes integrated battery energy storage, located in southern Bulgaria.

The agreement marks a significant step for Teva in securing renewable energy sources, while Enery benefits from a stable off-taker for its solar project. This collaboration highlights the growing trend of pharmaceutical companies investing in sustainable energy solutions to reduce their carbon footprint and support environmental initiatives.

How Does Teva's 15-Year Solar Agreement with Enery Impact Renewable Energy Trends in Pharmaceuticals?

  • Industry Leadership: Teva's agreement with Enery positions the company as a leader in the pharmaceutical industry's shift towards renewable energy, setting a precedent for others to follow.
  • Carbon Footprint Reduction: By committing to a long-term renewable energy source, Teva significantly reduces its carbon emissions, aligning with global sustainability goals and potentially influencing industry standards.
  • Energy Cost Stability: The 15-year agreement provides Teva with predictable energy costs, which can lead to financial stability and potentially lower operational costs over time.
  • Enhanced Corporate Image: This move enhances Teva's corporate image as an environmentally responsible company, which can improve stakeholder relations and customer loyalty.
  • Encouragement for Innovation: The integration of battery energy storage in the solar farm encourages further innovation in energy solutions, potentially leading to more efficient and sustainable practices within the pharmaceutical industry.
  • Market Influence: Teva's commitment may influence other pharmaceutical companies to explore similar agreements, accelerating the adoption of renewable energy across the sector.
  • Regulatory Compliance: Aligning with renewable energy trends helps Teva meet current and future regulatory requirements related to environmental impact and sustainability.
  • Supply Chain Impact: The agreement may encourage Teva's suppliers and partners to adopt renewable energy practices, creating a ripple effect throughout the supply chain.
  • Investment in Local Economies: The solar farm in Bulgaria represents an investment in local economies, potentially leading to job creation and economic growth in the region.
  • Long-term Sustainability Goals: This agreement supports Teva's long-term sustainability goals, contributing to a broader corporate strategy focused on environmental responsibility.